NCT00920049 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Arnett JJ
Developmental sources of crash risk in young drivers. Inj Prev. 2002 Sep;8 Suppl 2:ii17-21; discussion ii21-3.
Foss R, Goodwin A
Enhancing the effectiveness of graduated driver licensing legislation. J Safety Res. 2003 Jan;34(1):79-84.
Hartos JL, Nissen WJ, Simons-Morton BG
Acceptability of the Checkpoints Parent-Teen Driving Agreement: pilot test. Am J Prev Med. 2001 Aug;21(2):138-41.

Preventing Motor Vehicle Crashes Among Young Drivers: Evaluation of the AAA Checkpoints Program

Clinical trial NCT00920049 - References